Tumor growth decreases NK and B cells as well as common lymphoid progenitor

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Richards, John ^a   McNally, Beth ^a,b   Fang, Xianfeng ^b,c   Caligiuri, Michael A ^a   Zheng, Pan ^b   Liu, Yang ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CELL COUNT; CELL LINEAGE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; HOST RESISTANCE; LYMPHOID CELL; LYMPHOPOIESIS; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; THYMOMA; TUMOR GROWTH; TUMOR IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER TRANSPLANTATION; CYTOLOGY; CYTOTOXICITY; IMMUNOLOGY; LYMPHOID PROGENITOR CELL; METABOLISM; NEOPLASM; TRANSGENIC MOUSE; TUMOR CELL LINE;

MUS;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; INTERLEUKIN-15; KILLER CELLS, NATURAL; LYMPHOID PROGENITOR CELLS; LYMPHOPOIESIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; NEOPLASMS;

EID: 52649127904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003180     Document Type: Article

References (33)

1. Akashi K, Traver D, Miyamoto T, Weissman IL (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197.
2. Hoang T (2004) The origin of hematopoietic cell type diversity. Oncogene 23: 7188-7198.
3. Zhu J, Emerson SG (2002) Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 21: 3295-3313.
4. Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, et al. (2004) Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 53: 64-72.
5. Melani C, Chiodoni C, Forni G, Colombo MP (2003) Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102: 2138-2145.
6. Richards J, Xing C, Blaser BW, Caligiuri MA, Zheng P, et al. (2006) Tumor growth impedes natural-killer cell maturation in the bone marrow. Blood.
7. McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, et al. (2000) Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95: 3489-3497.
8. Kennedy MK, Glaccum, M, Brown SN, Butz EA, Viney JL, et al. (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191: 771-780.
9. Sitnicka E, Bryder D, Theilgaard-Monch K, Buza-Vidas N, Adolfsson J, et al. (2002) Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17: 463-472.
10. Yu H, Fehniger TA, Fuchshuber P, Thiel KS, Vivier E, et al. (1998) Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 92: 3647-3657.
11. Williams NS, Klem J, Puzanov IJ, Sivakumar PV, Bennett M, et al. (1999) Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells. J Immunol 163: 2648-2656.
12. Seaman WE, Talal N (1981) Natural killing by spleen cells from W/Wv and Sl/Sld anemic mice. Exp Hematol 9: 691-696.
13. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, et al. (1998) IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
14. Suzuki H, Duncan GS, Takimoto H, Mak TW (1997) Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J Exp Med 185: 499-505.
15. Minagawa M, Watanabe H, Miyaji C, Tomiyama K, Shimura H, et al. (2002) Enforced expression of Bcl-2 restores the number of NK cells, but does not rescue the impaired development of NKT cells or intraepithelial lymphocytes, in IL-2/IL-15 receptor beta-chain-deficient mice. J Immunol 169: 4153-4160.
16. Cooper MA, Bush JE, Fehniger TA, VanDeusen JB, Waite RE, et al. (2002) In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100: 3633-3638.
17. Pierson BA, Miller JS (1996) CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Blood 88: 2279-2287.
18. Fehniger TA, Suzuki K, Ponnappan A, VanDeusen JB, Cooper MA, et al. (2001) Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med 193: 219-231.
19. Hackett J Jr, Bosma GC, Bosma MJ, Bennett M, Kumar V (1986) Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc Natl Acad Sci U S A 83: 3427-3431.
20. Haller O, Kiessling R, Orn A, Wigzell H (1977) Generation of natural killer cells: an autonomous function of the bone marrow. J Exp Med 145: 1411-1416.
21. Mellqvist UH, Hansson M, Brune M, Dahlgren C, Hermodsson S, et al. (2000) Natural killer cell dysfunction and apoptosis induced by chronic myclogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood 96: 1961-1968.
22. Bauernhofer T, Kuss I, Henderson B, Baum AS, Whiteside TL (2003) Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur J Immunol 33: 119-124.
23. Williams NS, Moore TA, Schatzle JD, Puzanov IJ, Sivakumar PV, et al. (1997) Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J Exp Med 186: 1609-1614.
24. Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, et al. (2001) Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 31: 1900-1909.
25. Spangrude GJ, Heimfeld S, Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
26. Kondo M, Weissman IL, Akashi K (1997) Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
27. Kusmartsev S, Gabrilovich DI (2002) Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother 51: 293-298.
28. Bronte V, Serafini P, Apolloni E, Zanovello P (2001) Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunother 24: 431-446.
29. Byrne AM, Bouchier-Hayes DJ, Harmey JH (2005) Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 9: 777-794.
30. Kusmartsev S, Gabrilovich DI (2006) Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother 55: 237-245.
31. Geldhof AB, van Ginderachter JA, Liu Y, Noel W, de Baetselier P (2003) Ablation of NK cell function during tumor growth favors Type 2-associated macrophages, leading to suppressed CTL generation. Clin Dev Immunol 10: 71-81.
32. Prlic M, Blazar BR, Farrar MA, Jameson SC (2003) In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med 197: 967-976.
33. de Jonge WJ, Kwikkers KL, te Velde AA, van Deventer SJ, Nolte MA, et al. (2002) Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice. J Clin Invest 110: 1539-1548.